Plus: Home-building slowed more than expected in August. And Eli Lilly says its investigational diabetes pill outperformed Novo Nordisk’s oral semaglutide in a clinical trial. Zoe Kuhlkin hosts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Aug 2024
U.S. Jobs Growth Slows, Rocking Markets, Fueling Bets on Big Rate Cut
P.M. Edition for Aug. 2. The U.S. is still adding jobs, but no longer at a red-hot pace. That sent markets into a tailspin, and economics reporter Justin Lahart says an interest rate cut in September now looks all but guaranteed in order to steer clear of recession. And WSJ repor ... Show More
15m 17s